ClinVar Miner

Submissions for variant NM_000046.5(ARSB):c.1340G>T (p.Cys447Phe)

dbSNP: rs1465993279
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova RCV000677480 SCV000802989 uncertain significance Mucopolysaccharidosis type 6 2018-01-01 criteria provided, single submitter curation Absent from GnomAD (PM2)
Invitae RCV000677480 SCV000938808 pathogenic Mucopolysaccharidosis type 6 2023-01-26 criteria provided, single submitter clinical testing Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ARSB protein function. ClinVar contains an entry for this variant (Variation ID: 559706). This missense change has been observed in individual(s) with mucopolysaccharidosis type VI (PMID: 17458871, 17643332, 26909334). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces cysteine, which is neutral and slightly polar, with phenylalanine, which is neutral and non-polar, at codon 447 of the ARSB protein (p.Cys447Phe). Experimental studies have shown that this missense change affects ARSB function (PMID: 17458871). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Cys447 amino acid residue in ARSB. Other variant(s) that disrupt this residue have been observed in individuals with ARSB-related conditions (PMID: 17458871), which suggests that this may be a clinically significant amino acid residue.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.